Connect with us

cannabis policy

Trump Admin Asks Congress to Regulate Full-Spectrum Hemp Products or Delay Federal Crackdown

Published

on

Trump Admin Asks Congress to Regulate Full-Spectrum Hemp Products or Delay Federal Crackdown

The Trump administration this week asked Congress to either regulate full-spectrum hemp CBD products or delay an upcoming federal crackdown targeting hemp-derived THC products. Marijuana moment reports.

Russell T. Vought, who has served in the administration as director of the Office of Management and Budget since February 2024, called for the reforms Wednesday in a paper addressed to Rep. Mike Johnson (R), Speaker of the House of Representatives.

The letter states that the White House “strongly supports” changing federal law to regulate specific hemp products instead of banning the category entirely — “or, at the very least, an extension of the implementation of the regulatory framework” that will take effect in less than five months.

Currently, it is governed by a federal spending bill that President Trump (R) signed into law At the end of last year will come into effect on November 12, which contain new THC restrictions that ban almost all consumable hemp products.

The president said on social media in April that lawmakers should pass legislation protecting Americans’ access to full-spectrum hemp CBD products.

Based in Portland, Oregon, Graham is the editor-in-chief of Ganjapreneur. He has been writing about the legalization landscape since 2012 and has contributed to Ganjapreneur since our official launch in…

Continue Reading

cannabis policy

Massachusetts Cannabis Legalization Repeal Effort Qualifies for November Ballot

Published

on

By

Massachusetts Cannabis Legalization Repeal Effort Qualifies for November Ballot

Massachusetts officials have confirmed that a ballot initiative seeking to overturn the state’s law legalizing adult cannabis will go before voters in November. Marijuana moment reports.

The Elections Division of the Secretary of the Commonwealth’s Office informed organizers last week that they had submitted 12,551 verified signatures during the second round of petitioning, narrowly clearing the requirement of 12,429 signatures for the Nov. 3, 2026 state election ballot. Under Massachusetts law, ballot campaigns must submit signatures in two rounds, with the Legislature given an opportunity to approve the proposed measures after the first presentation. Lawmakers declined to act on the cannabis proposal in May.

If approved by voters, the measure would repeal laws allowing regulated sales of adult-use cannabis and home cultivation, leaving the state’s legal possession and medical cannabis program intact. A coalition of cannabis business leaders, health care professionals and advocates has started a campaign opposing the proposal.

The campaign behind the repeal measure, the Coalition for a Healthy Massachusetts, previously suspended a signature gatherer after a video surfaced showing the person using fraudulent arguments while gathering signatures for the Massachusetts initiative and a similar proposal in Maine. The campaign said it has “zero tolerance” for fraudulent traffic tactics.

Cannabis advocates had opposed the Massachusetts proposal on grounds that included allegedly deceptive signature-gathering tactics, unrelated topics and an allegedly deficient official summary, but their effort was rejected by the State Voting Law Commission and the state’s Supreme Judicial Court. After last week’s decision, cannabis businesses in Massachusetts came forward another challenge until repeal.

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

Continue Reading

cannabis policy

Wyoming Drugs Commissioner Will Not Reschedule Cannabis Under State Law Despite Federal Reforms 

Published

on

By

Wyoming Drugs Commissioner Will Not Reschedule Cannabis Under State Law Despite Federal Reforms 

The Wyoming Attorney General’s Office said the state will not reschedule cannabis under state law, regardless federal reforms the movement of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. In a policy statement released last week, the attorney general’s office said the state has already scheduled Food and Drug Administration (FDA)-approved pharmaceutical cannabis drugs — such as Dronabinol and Cesamet — as Schedule III and Schedule II drugs, respectively, and that Epidiolex has been completely removed from the state’s drug schedule.

The ruling states that state lawmakers have not legalized cannabis for any purpose in the state or recognized any other state’s medical cannabis licenses.

“Therefore, placing marijuana subject to a state medical marijuana license in Schedule III of the Wyoming Controlled Substances Act is inconsistent with the police powers heretofore exercised by the Wyoming Legislature. – Wyoming Attorney General’s Office, “Final Decision of the Commissioner of Drug and Substance Control Regarding the Placement of FDA-Approved Drug Products Containing Marijuana and Marijuana Under State License in Schedule III of the Wyoming Substances Act,” 7/7/26

The announcement adds that during a hearing in June regarding potential state rescheduling of cannabis, eight comments were received from the Drug and Substance Abuse Commissioner. Comments were evenly split between maintaining the status quo and rescheduling cannabis in Schedule III.

The order states that the commissioner “shall appropriately schedule products approved by the (FDA) after that agency has approved the product.”

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He is based in upstate New York, where he also teaches media at a local university.

Continue Reading

adult use

Kansas Governor Candidate Pushes Cannabis Legalization Platform

Published

on

By

Kansas Governor Candidate Pushes Cannabis Legalization Platform

The Democratic front-runner for governor of Kansas is calling for the legalization of medical and adult cannabis in the state. In one video posted on Facebook from the parking lot of a dispensary in Missouri — just across the state line from her Johnson County home, state Sen. Cindy Holscher noted that the place was “full of Kansas license plates.”

“That’s a lot of Kansas tax dollars going straight into Missouri’s pocket. Most Kansas voters think marijuana should be legal in our state, but because it’s not Kansas, we buy it out of state and we miss the opportunity to raise more money for schools and public services.” — Holscher in a video posted to Facebook

Holscher noted that last year Missouri collected $255 million in tax dollars from cannabis sales in the state.

“This is real money that can make a big difference for Kansans,” Holscher said in the video. “Legalization means we will build an industry in Kansas of farmers and small businesses and keep our tax dollars in the state to benefit our schools.”

Holscher added that legalizing cannabis is “common sense” and that adults should be allowed to consume cannabis “safely and responsibly”.

or last survey by Change Research, commissioned by Civic Clarity, which operates the Capitol Bee news entity, found Holscher with 37% support among poll respondents, while Johnson County state Sen. Ethan Corson received 10% support and Overland Park Mayor Curt Skoog at 7%.

or Kansas Speaks Poll published in February found that 70% of Kansans support the legalization of medical cannabis, while 60% support adult-use reforms.

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media